Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BioShare AB
AB
Active
Org 5591098024
Steffens Väg 431, 655 92
Karlstad
Manufacture of other special-purpose machinery n.e.c.
·
NACE 2899
Est. 2017 · 9 years old
7 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other special-purpose machinery n.e.c.
/
BioShare AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
11M
8M
6M
3M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 8M
8M
2023
2024: 9M (+13% vs 2023)
9M
+13%
2024
2025: 1M (-89% vs 2024)
1M
-89%
2025
EBITDA
SEK millions
0M
-1M
-2M
-4M
-5M
2021: -4M
-4M
2021
2022: -1M (+75% vs 2021)
-1M
+75%
2022
2023: -1M (0% vs 2022)
-1M
0%
2023
2024: 0M (+100% vs 2023)
0M
2024
2025: -3M
-3M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
981
9 037
8 159
425
218
Staff expenses
−5 896
−4 296
−3 784
−3 856
—
EBITDA
−2 989
−315
−1 485
−1 346
−3 677
Depreciation & amort.
−1 172
−680
−453
—
−0
EBIT
−4 161
−995
−1 938
−1 346
−3 677
Net financials
−235
60
137
24
−1
Profit before tax
−4 396
−984
−1 801
−1 322
−3 678
Tax
—
—
—
—
−0
Net profit
−4 396
−984
−1 801
−1 322
−3 678
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
7 308
7 423
17 508
13 710
15 586
Equity
2 999
5 395
6 379
8 179
9 501
Long-term debt
1 378
—
—
—
0
Short-term debt
2 931
2 028
11 129
5 531
6 084
Total debt
4 310
2 028
11 129
5 531
6 084
Financial ratios
5-year trend
EBITDA margin
−304,7 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
41,0 %
This company
38,2 %
Market median
This company
Market median
7% above market
2021
2025
Return on equity
−146,6 %
This company
18,4 %
Market median
This company
Market median
897% below market
2021
2025
Net profit margin
−448,1 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,13×
This company
1,12×
Market median
This company
Market median
88% below market
2021
2025
Debt / equity
1,44×
This company
0,62×
Market median
This company
Market median
132% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on BioShare AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
